Cargando…

Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade

Immune checkpoint blockade (ICB) therapy is a revolutionary approach to treat cancers, but still have limited clinical applications. Accumulating evidence pinpoints the immunosuppressive characteristics of the tumor microenvironment (TME) as one major obstacle. The TME, characterized by acidity, hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Tianxu, Cao, Xiaona, Wang, Li, Chen, Mo, Deng, Yueyang, Chen, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660011/ https://www.ncbi.nlm.nih.gov/pubmed/38026439 http://dx.doi.org/10.1016/j.bioactmat.2023.10.023

Ejemplares similares

Designing bioresponsive nanomaterials for intracellular self-assembly
por: Chagri, Sarah, et al.
Publicado: (2022)

Editorial: Bioresponsive nanomaterials for drug delivery or controlled release
por: Pan, Yan, et al.
Publicado: (2023)

Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy
por: Zeng, Zeng, et al.
Publicado: (2022)

Microenvironment Stimulated Bioresponsive Small Molecule Carriers for Radiopharmaceuticals
por: Chaturvedi, Shubhra, et al.
Publicado: (2020)

Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2023)

Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade
por: Abril-Rodriguez, Gabriel, et al.
Publicado: (2022)

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
por: Liu, Senbo, et al.
Publicado: (2023)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)

Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis
por: Yang, Fang, et al.
Publicado: (2017)

Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment
por: Falcomatà, Chiara, et al.
Publicado: (2022)

Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response
por: Cai, Yonghua, et al.
Publicado: (2022)

Bioresponsive matrices in drug delivery
por: You, Jin-Oh, et al.
Publicado: (2010)

Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
por: Fang, Tianxu, et al.
Publicado: (2022)

Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
por: Ma, Xianbin, et al.
Publicado: (2022)

Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems
por: Wang, Junqing, et al.
Publicado: (2017)

The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
por: Russell, Bonnie L., et al.
Publicado: (2021)

Bioresponsive Polymers for Nanomedicine—Expectations and Reality!
por: Quader, Sabina, et al.
Publicado: (2022)

Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
por: Heij, Lara, et al.
Publicado: (2023)

Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
por: Lu, Chia-Sing, et al.
Publicado: (2020)

Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
por: Liu, Senbo, et al.
Publicado: (2022)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
por: Harber, James, et al.
Publicado: (2021)

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
por: Genova, Carlo, et al.
Publicado: (2022)

Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
por: Hubert, Pascale, et al.
Publicado: (2021)

Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
por: Singh, Neetu, et al.
Publicado: (2011)

Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades
por: Li, Jun-Yan, et al.
Publicado: (2021)

Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy
por: Li, Yanan, et al.
Publicado: (2021)

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
por: Ruan, Ruiwen, et al.
Publicado: (2023)

Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy
por: Subramanian, Madhav, et al.
Publicado: (2023)

Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
por: Lin, Chia-Yi, et al.
Publicado: (2023)

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors
por: Sun, Lu, et al.
Publicado: (2023)

The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment
por: Luo, Hong, et al.
Publicado: (2023)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
por: Lee, Yu-Hung, et al.
Publicado: (2021)

C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
por: Zhang, Chen, et al.
Publicado: (2023)

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
por: Xiao, Yuling, et al.
Publicado: (2022)

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
por: Jelinic, Petar, et al.
Publicado: (2018)

Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
por: Kim, Min Hwan, et al.
Publicado: (2020)

Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
por: Pingili, Ajeeth K., et al.
Publicado: (2021)

Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition
por: Purcell, Brendan P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gs0erb9c50v7sur761k3i2sceb